Logo image of IZ.CA

INTERNATIONAL ZEOLITE CORP (IZ.CA) Stock Fundamental Analysis

TSX-V:IZ - TSX Venture Exchange - CA4605821095 - Common Stock - Currency: CAD

0.01  0 (0%)

Fundamental Rating

0

Taking everything into account, IZ scores 0 out of 10 in our fundamental rating. IZ was compared to 0 industry peers in the Unkown industry. IZ may be in some trouble as it scores bad on both profitability and health. IZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IZ has reported negative net income.
In the past year IZ has reported a negative cash flow from operations.
IZ had negative earnings in each of the past 5 years.
IZ had a negative operating cash flow in each of the past 5 years.
IZ.CA Yearly Net Income VS EBIT VS OCF VS FCFIZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -76.77%
ROE N/A
ROIC N/A
ROA(3y)-113.55%
ROA(5y)-84.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IZ.CA Yearly ROA, ROE, ROICIZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

In the last couple of years the Gross Margin of IZ has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for IZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y0.61%
IZ.CA Yearly Profit, Operating, Gross MarginsIZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

IZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
IZ has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, IZ has more shares outstanding
IZ has a worse debt/assets ratio than last year.
IZ.CA Yearly Shares OutstandingIZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
IZ.CA Yearly Total Debt VS Total AssetsIZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

Based on the Altman-Z score of -63.16, we must say that IZ is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -63.16
ROIC/WACCN/A
WACC5.63%
IZ.CA Yearly LT Debt VS Equity VS FCFIZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

2.3 Liquidity

IZ has a Current Ratio of 0.10. This is a bad value and indicates that IZ is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.05 indicates that IZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.05
IZ.CA Yearly Current Assets VS Current LiabilitesIZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

IZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.47%, which is quite impressive.
Looking at the last year, IZ shows a very negative growth in Revenue. The Revenue has decreased by -31.49% in the last year.
Measured over the past years, IZ shows a decrease in Revenue. The Revenue has been decreasing by -1.54% on average per year.
EPS 1Y (TTM)80.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.27%
Revenue 1Y (TTM)-31.49%
Revenue growth 3Y6.1%
Revenue growth 5Y-1.54%
Sales Q2Q%-45.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IZ.CA Yearly Revenue VS EstimatesIZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
IZ.CA Yearly EPS VS EstimatesIZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IZ.CA Price Earnings VS Forward Price EarningsIZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IZ.CA Per share dataIZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTERNATIONAL ZEOLITE CORP

TSX-V:IZ (3/7/2025, 7:00:00 PM)

0.01

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-21 2025-02-21
Earnings (Next)05-14 2025-05-14
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners17.33%
Ins Owner ChangeN/A
Market Cap424.10K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.49%
FCFM N/A
ROA(3y)-113.55%
ROA(5y)-84.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.22%
GM growth 5Y0.61%
F-Score3
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.05
Altman-Z -63.16
F-Score3
WACC5.63%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)8.13%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.49%
Revenue growth 3Y6.1%
Revenue growth 5Y-1.54%
Sales Q2Q%-45.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.6%
OCF growth 3YN/A
OCF growth 5YN/A